Pegasys Better Than PegIntron?
From the following article it seems there is a real advantage for Hepatitis c patients to choose Pegasys from Roche... View Article
Continue reading »From the following article it seems there is a real advantage for Hepatitis c patients to choose Pegasys from Roche... View Article
Continue reading »Perhaps the most telling part of the following announcment is the acknowledgment of the fact that genotype is one of... View Article
Continue reading »The following report caught my eye for several reasons. First of all, I am surprised this study was even reported... View Article
Continue reading »A while back I wrote about a biopsy alternative called Fibrospect. Here is yet another blood test based alternative that... View Article
Continue reading »More Effective Interferon Dosing For HCV Genotype 1 This new trial result is very revealing. Especially given the fact that 70% of chronic Hepatitis c patients in the USA have genotype 1. Note the success rates (along with the failure rates). Apparently with this "improved" method of dosing they got up to 41%. and the drop out rate was only 19%. Now take a closer look at the rates they compare against. These are for the currently accepted standard dosing.
Continue reading »You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window